Stelle Isabella, Bah Mamadou, Verhoef Hans, Moore Sophie, Cerami Carla
Department of Women and Children's Health, King's College London, London, MO, UK.
MRC Unit, The Gambia at LSHTM, Banjul, Banjul, Gambia.
BMJ Nutr Prev Health. 2025 Jan 11;8(1):e000847. doi: 10.1136/bmjnph-2023-000847. eCollection 2025.
In a randomised placebo-controlled trial among exclusively breastfed rural Gambian infants aged 6-10 weeks at randomisation, daily iron supplementation for 14 weeks improved iron status. This secondary analysis explores the impact of iron supplementation on duration of exclusive breastfeeding and growth.
Breastfed 6-10 week-old infants were supplemented for 14 weeks with either daily iron or placebo (n=101). Infant feeding practices were assessed weekly through questionnaires. Survival analysis was used to measure the effect of iron supplementation on age at and time to cessation of exclusive breastfeeding. Groups were also compared regarding the change in anthropometric z-scores between baseline and endline.
At endline, 31% (n=31/101) of infants were exclusively breastfed. There was no evidence that iron supplementation reduced the time to cessation of exclusive breastfeeding (median: 70 days (range: 7-105 days), iron: 67 days; placebo 71 days; Kaplan-Meier, log-rank test: p=0.15; Cox regression, crude HR: 1.42, 95% CI: 0.86 to 2.34, p=0.17; HR adjusting for infant age and sex: 1.40, 95% CI: 0.85 to 2.31, p=0.19) or age at cessation of exclusive breastfeeding (median time: 18 weeks (range:1-24 weeks), iron: 16 weeks; placebo 18 weeks; Kaplan-Meier, log-rank test: p=0.13; crude HR=1.47, 95% CI: 0.89, 2.43; p=0.13; HR adjusting for infant age and sex=1.44, 95% CI: 0.87, 2.39 p=0.16) There was no evidence that iron supplementation affected infant weight (p=0.79) or length (p=0.64) at endline or change in z-scores during the intervention period for weight-for-age (p=0.99), length-for-age (p=0.70) and weight-for-length (p=0.89). There was no evidence that duration of exclusive breastfeeding impacted endline anthropometric outcomes.
Although requiring replication in larger trials, these findings do not raise concerns about iron supplementations' effect on feeding or growth in exclusively breastfed infants.
在一项随机安慰剂对照试验中,对随机分组时年龄为6 - 10周的冈比亚农村纯母乳喂养婴儿进行了为期14周的每日铁补充,结果显示铁补充改善了铁状态。这项二次分析探讨了铁补充对纯母乳喂养持续时间和生长的影响。
对6 - 10周龄的母乳喂养婴儿补充14周的每日铁剂或安慰剂(n = 101)。通过问卷调查每周评估婴儿喂养方式。采用生存分析来衡量铁补充对纯母乳喂养停止年龄和停止时间的影响。还比较了两组在基线和结束时人体测量学z评分的变化。
在结束时,31%(n = 31/101)的婴儿仍在纯母乳喂养。没有证据表明铁补充会缩短纯母乳喂养停止时间(中位数:70天(范围:7 - 105天),铁剂组:67天;安慰剂组:71天;Kaplan - Meier对数秩检验:p = 0.15;Cox回归,粗风险比:1.42,95%置信区间:0.86至2.34,p = 0.17;调整婴儿年龄和性别的风险比:1.40,95%置信区间:0.85至2.31,p = 0.19)或纯母乳喂养停止年龄(中位数时间:18周(范围:1 - 24周),铁剂组:16周;安慰剂组:18周;Kaplan - Meier对数秩检验:p = 0.13;粗风险比 = 1.47,95%置信区间:0.89,2.43;p = 0.13;调整婴儿年龄和性别的风险比 = 1.44,95%置信区间:0.87,2.39,p = 0.16)。没有证据表明铁补充会影响结束时婴儿的体重(p = 0.79)或身长(p = 0.64),也没有证据表明在干预期间年龄别体重(p = 0.99)、年龄别身长(p = 0.70)和身长别体重(p = 0.89)的z评分会发生变化。没有证据表明纯母乳喂养持续时间会影响结束时的人体测量学结果。
尽管需要在更大规模试验中进行重复验证,但这些发现并未引发对铁补充对纯母乳喂养婴儿喂养或生长影响的担忧。